Wealth Enhancement Advisory Services
FOLD

Wealth Enhancement Advisory Services’s Amicus Therapeutics FOLD Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-38,254
Closed -$552K – 4176
2026
Q1 		$552K Buy
38,254
+928
+2% +$13.3K ﹤0.01% 2238
2025
Q4 		$533K Buy
37,326
+13,443
+56% +$132K ﹤0.01% 2423
2025
Q3 		$195K Buy
+23,883
New +$170K ﹤0.01% 3156

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wealth Enhancement Advisory Services's FOLD Position: Q2 2026 in Review

Wealth Enhancement Advisory Services sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 38,254 shares — an estimated $552K sold.

Wealth Enhancement Advisory Services first reported a position in FOLD in Q3 2025 and held it in 3 quarters. The position peaked at $552K in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

  • Wealth Enhancement Advisory Services reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 38,254 Amicus Therapeutics shares in Q2 2026, an estimated $552K.
  • Wealth Enhancement Advisory Services first reported a position in Amicus Therapeutics in Q3 2025 and held it in 3 quarters.
  • Wealth Enhancement Advisory Services's Amicus Therapeutics position peaked at $552K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.